Rare Mutations in Cancer Drug Resistance and Implications for Therapy

Clin Pharmacol Ther. 2020 Sep;108(3):437-439. doi: 10.1002/cpt.1938. Epub 2020 Jul 10.

Authors

Robert A Beckman¹, Lawrence A Loeb²

Affiliations

¹ Departments of Oncology and of Biostatistics, Bioinformatics, and Biomathematics, Lombardi Comprehensive Cancer Center and Innovation Center for Biomedical Informatics, Georgetown University Medical Center, Washington, DC, USA.
² Departments of Pathology and Biochemistry, University of Washington School of Medicine, Seattle, Washington, USA.

No abstract available

Publication types

Research Support, N.I.H., Extramural

MeSH terms

Antineoplastic Agents / therapeutic use*
Biomarkers, Tumor / genetics*
Drug Resistance, Neoplasm / genetics*
Genetic Heterogeneity
Genetic Predisposition to Disease
Humans
Mutation*
Neoplasms / drug therapy*
Neoplasms / genetics*
Neoplasms / pathology
Risk Factors

Substances

Antineoplastic Agents
Biomarkers, Tumor

Grants and funding